ALEMBIC PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

With reference to the captioned subject, this is to inform the exchange that the Company has received US Food & Drug Administration (USFDA) Final Approval for Diclofenac Sodium Topical Solution USP, 2% w/w. Please find enclosed herewith our press release. We request you to kindly take the same on record.